Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.45 is 37% below its 5-year average of 2.32, near the low end of its 5-year range (1.25–23.87).
As of the fiscal period ended Tuesday, June 30, 2026. 15.20% below its 12-month average of 1.72.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.45.
CURRENT RATIO
1.45
CURRENT RATIO AVG TTM
1.72
CURRENT RATIO AVG 3Y
2.10
CURRENT RATIO AVG 5Y
2.32
CURRENT RATIO AVG 10Y
8.63
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.20%
CURRENT VS 3Y AVG
-30.76%
CURRENT VS 5Y AVG
-37.19%
CURRENT VS 10Y AVG
-83.15%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-61.22%
vs the sector median at left
Verrica Pharmaceuticals Inc.
Market Cap
$70.60M
Current Ratio
1.45
TTM Avg
1.72
3Y Avg
2.10
5Y Avg
2.32
Market Cap
$67.66M
Current Ratio
1.03
TTM Avg
0.95
3Y Avg
0.86
5Y Avg
0.95
Market Cap
$69.19M
Current Ratio
6.12
TTM Avg
4.89
3Y Avg
4.59
5Y Avg
6.09
Market Cap
$68.40M
Current Ratio
0.76
TTM Avg
0.89
3Y Avg
1.63
5Y Avg
3.63
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | $70.60M | 1.45 | 1.72 | 2.10 | 2.32 |
| MindWalk Holdings Corp. (HYFT)vs › | $72.36M | 1.84 | 2.44 | 2.28 | 3.54 |
| Gain Therapeutics, Inc. (GANX)vs › | $71.15M | 4.36 | 4.80 | 4.58 | 6.22 |
| Hyperfine, Inc. (HYPR)vs › | $74.03M | 6.15 | 5.25 | 8.81 | 10.73 |
| Pulmonx Corporation (LUNG)vs › | $75.39M | 4.32 | 5.33 | 6.57 | 9.68 |
| Champions Oncology, Inc. (CSBR)vs › | $67.66M | 1.03 | 0.95 | 0.86 | 0.95 |
| SkinHealth Systems Inc. (SKIN)vs › | $75.75M | 1.76 | 4.33 | 6.41 | 6.77 |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.19M | 6.12 | 4.89 | 4.59 | 6.09 |
| Tiziana Life Sciences Ltd (TLSA)vs › | $68.40M | 0.76 | 0.89 | 1.63 | 3.63 |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | 1.98 | 1.80 | 2.98 | 4.38 |
Current Ratio
1.45
Quick Ratio
1.33
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.45 |
| 2026-03-31 | 2.02 |
| 2025-12-31 | 2.59 |
| 2025-09-30 | 1.25 |
| 2025-06-30 | 1.26 |
| 2025-03-31 | 1.34 |
| 2024-12-31 | 1.76 |
| 2024-09-30 | 1.34 |
| 2024-06-30 | 2.36 |
| 2024-03-31 | 3.17 |
| 2023-12-31 | 4.55 |
| 2023-09-30 | 8.06 |
| 2023-06-30 | 9.91 |
| 2023-03-31 | 23.87 |
| 2022-12-31 | 11.31 |
| 2022-09-30 | 14.10 |
| 2022-06-30 | 1.25 |
| 2022-03-31 | 1.47 |
| 2021-12-31 | 1.61 |
| 2021-09-30 | 1.79 |
| 2021-06-30 | 2.06 |
| 2021-03-31 | 2.29 |
| 2020-12-31 | 1.71 |
| 2020-09-30 | 1.90 |
| 2020-06-30 | 2.15 |
| 2020-03-31 | 27.45 |
| 2019-12-31 | 19.39 |
| 2019-09-30 | 17.10 |
| 2019-06-30 | 18.63 |
| 2019-03-31 | 27.65 |
| 2018-12-31 | 36.80 |
| 2018-09-30 | 40.26 |
| 2018-06-30 | 33.47 |
| 2018-03-31 | 17.54 |
| 2017-12-31 | 14.75 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
